Reviewed September 16, 2026 · For B2B procurement and development teams
Choose by matching the primary container, dose logic, activation sequence, reuse model, user environment and evidence requirements before comparing appearance or unit price.
Start with the device requirement, not the catalog image
The right injection pen is the platform that fits the written device requirement with the fewest unsupported assumptions. Begin with the primary container, nominal volume, route of administration, dose range and increment, required delivery time, force profile, reuse model and target user environment. Then identify safety, feedback, accessibility, storage and disposal needs. A pen that looks appropriate can still fail because the cartridge interface, drive force, needle system, material compatibility or dose accuracy does not match the program. Separate mandatory inputs from preferences and record unknowns. This gives the manufacturer enough information to screen existing platforms, identify necessary changes and flag where drug-device, human-factors or regulatory specialists must be involved.
Compare platform routes and commercial consequences
A standard reusable or disposable platform may minimize tooling and shorten the sample cycle, but it also limits changes. Semi-custom OEM usually allows controlled color, finish, logo, packaging and selected configuration options. Full custom OEM or ODM can address geometry, mechanism, interface or electronics, but it adds design reviews, tooling, prototypes, verification work and change control. Ask each supplier to classify the proposed route and list what is standard, modified and new. The quotation should separate samples, engineering, tooling, testing, packaging setup and recurring unit price. This makes proposals comparable and prevents a low standard-platform price from being applied to a later custom brief.
Use an evidence-based shortlist
Shortlist suppliers only after asking for a configuration-specific response. Request the proposed model, interface assumptions, material direction, available samples, indicative MOQ, development route, evidence package and known exclusions. Verify any certificate by entity, site, scope, issuer and validity. Ask who will act as legal manufacturer and which party owns market submissions, artwork and tooling. A credible supplier will identify missing information and boundaries rather than promise immediate approval or universal compatibility. Score proposals across technical fit, evidence, change control, supply resilience, communication and total program cost. The best answer is usually the one that exposes risk early and provides a controlled path to close it.
Next procurement step
Convert the guidance above into a one-page requirement matrix and share it with candidate suppliers. Include the device architecture, target market, primary container, dose concept, annual forecast, customization scope, desired sample purpose and required evidence. Ask each supplier to respond against the same fields, identify assumptions and state which items remain unverified. HYTANBIO can review that brief to determine whether a standard platform, semi-custom OEM path or full ODM program is the most appropriate starting point.
Questions buyers also ask
The target device architecture and primary-container assumptions are usually the most important technical starting points.
No. Compare engineering, tooling, testing, documentation, packaging, logistics, quality controls and recurring unit cost.
Verify the legal entity, site, scope, issuing body, accreditation, number and validity period.
No. The sample purpose and status must be stated; only an approved production baseline controls release.
Yes. State which inputs are confirmed and which remain open so the review can focus on feasibility and next decisions.